Your browser doesn't support javascript.
loading
Surgical complications after living and deceased donor liver transplant: The NSQIP transplant experience.
Amara, Dominic; Parekh, Justin; Sudan, Debra; Elias, Nahel; Foley, David P; Conzen, Kendra; Grieco, Arielle; Braun, Hillary J; Greenstein, Stuart; Byrd, Claudia; Ko, Clifford; Hirose, Ryutaro.
Afiliação
  • Amara D; School of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Parekh J; Department of Surgery, University of California San Diego, San Diego, California, USA.
  • Sudan D; Department of Surgery, Duke University, Durham, North Carolina, USA.
  • Elias N; Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Foley DP; Department of Surgery, University of Wisconsin, Madison, Wisconsin, USA.
  • Conzen K; Department of Surgery, University of Colorado, Aurora, Colorado, USA.
  • Grieco A; American College of Surgeons, Chicago, Illinois, USA.
  • Braun HJ; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Greenstein S; Department of Surgery, Montefiore Medical Center, Bronx, New York, USA.
  • Byrd C; American College of Surgeons, Chicago, Illinois, USA.
  • Ko C; American College of Surgeons, Chicago, Illinois, USA.
  • Hirose R; Department of Surgery, University of California Los Angeles, Los Angeles, California, USA.
Clin Transplant ; 36(6): e14610, 2022 06.
Article em En | MEDLINE | ID: mdl-35143698
ABSTRACT
This study used the prospective National Surgical Quality Improvement Program (NSQIP) Transplant pilot database to analyze surgical complications after liver transplantation (LT) in LT recipients from 2017to 2019. The primary outcome was surgical complication requiring intervention (Clavien-Dindo grade II or greater) within 90 days of transplant. Of the 1684 deceased donor and 109 living donor LT cases included from 29 centers, 38% of deceased donor liver recipients and 47% of living donor liver recipients experienced a complication. The most common complications included biliary complications (19% DDLT; 31% LDLT), hemorrhage requiring reoperation (14% DDLT; 9% LDLT), and vascular complications (6% DDLT; 9% LDLT). Management of biliary leaks (35.3% ERCP, 38.0% percutaneous drainage, 26.3% reoperation) and vascular complications (36.2% angioplasty/stenting, 31.2% medication, 29.8% reoperation) was variable. Biliary (aHR 5.14, 95% CI 2.69-9.8, P < .001), hemorrhage (aHR 2.54, 95% CI 1.13-5.7, P = .024) and vascular (aHR 2.88, 95% CI .85-9.7, P = .089) complication status at 30-days post-transplant were associated with lower 1-year patient survival. We conclude that biliary, hemorrhagic and vascular complications continue to be significant sources of morbidity and mortality for LT recipients. Understanding the different risk factors for complications between deceased and living donor liver recipients and standardizing complication management represent avenues for continued improvement.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doadores Vivos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Doadores Vivos Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Clin Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos